Additional Proxy Soliciting Materials (definitive) (defa14a)
April 30 2019 - 6:36AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section
14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant
|
x
|
Filed by a Party other than the Registrant
|
o
|
Check the appropriate box:
|
¨
|
Preliminary
Proxy Statement
|
|
o
|
Confidential,
for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
¨
|
Definitive
Proxy Statement
|
|
x
|
Definitive
Additional Materials
|
|
o
|
Soliciting
Material under §240.14a-12
|
CHECKPOINT THERAPEUTICS, INC.
(Name of Registrant as Specified In
Its Charter)
(Name of Person(s) Filing Proxy Statement,
if other than the Registrant)
Payment of Filing Fee (Check the appropriate
box):
|
o
|
Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
(1)
|
Title
of each class of securities to which transaction applies:
|
|
|
|
|
(2)
|
Aggregate
number of securities to which transaction applies:
|
|
|
|
|
(3)
|
Per
unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which
the filing fee is calculated and state how it was determined):
|
|
|
|
|
(4)
|
Proposed
maximum aggregate value of transaction:
|
|
|
|
|
o
|
Fee
paid previously with preliminary materials.
|
|
o
|
Check
box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of
its filing.
|
|
(1)
|
Amount
Previously Paid:
|
|
|
|
|
(2)
|
Form,
Schedule or Registration Statement No.:
|
|
|
|
*** Exercise Your
Right to Vote *** Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to Be Held on June
12, 2019. Meeting Information CHECKPOINT THERAPEUTICS, INC. Meeting Type: Annual Meeting For holders as of: April 15, 2019 Date:
June 12, 2019 Time: 10:00 AM ET Location: Alston & Bird LLP 90 Park Avenue New York, New York 10016 You are receiving this
communication because you hold shares in the company named above. This is not a ballot. You cannot use this notice to vote these
shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet.
You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side). We encourage you
to access and review all of the important information contained in the proxy materials before voting. CHECKPOINT THERAPEUTICS,
INC. ATTN: GARRETT GRAY 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK, NY 10014 E70503-P22814 See the reverse side of this notice to obtain proxy materials and voting instructions.
See the reverse side
of this notice to obtain proxy materials and voting instructions. Before You Vote How to Access the Proxy Materials Proxy Materials
Available to VIEW or RECEIVE: NOTICE AND PROXY STATEMENT ANNUAL REPORT How to View Online: Have the information that is printed
in the box marked by the arrow (located on the following page) and visit: www.proxyvote.com. How to Request and Receive a PAPER
or E-MAIL Copy: If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for
requesting a copy. Please choose one of the following methods to make your request: 1) BY INTERNET: www.proxyvote.com 2) BY TELEPHONE:
1-800-579-1639 3) BY E-MAIL*: sendmaterial@proxyvote.com * If requesting materials by e-mail, please send a blank e-mail with
the information that is printed in the box marked by the arrow (located on the following page) in the subject line. XXXX XXXX
XXXX XXXX XXXX XXXX XXXX XXXX Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to
your investment advisor. Please make the request as instructed above on or before May 29, 2019 to facilitate timely delivery.
How To Vote E70504-P22814 Please Choose One of the Following Voting Methods Vote In Person: Many stockholder meetings have attendance
requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please
check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot
to vote these shares. Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed
in the box marked by the arrow (located on the following page) available and follow the instructions. Vote By Mail: You can vote
by mail by requesting a paper copy of the materials, which will include a proxy card. XXXX XXXX XXXX XXXX
Voting
Items The Board of Directors recommends you vote FOR the following: 1. Election of Directors Nominees: 01) Michael S. Weiss 02)
Christian Bechon 03) Scott Boilen 04) Neil Herskowitz 05) James F. Oliviero 06) Lindsay A. Rosenwald, M.D. 07) Barry Salzman The
Board of Directors recommends you vote FOR proposal 2. 2. The ratification of appointment of BDO USA, LLP as independent registered
public accounting firm for the year ending December 31, 2019. NOTE: Such other business as may properly come before the meeting
or any adjournment thereof. E70505-P22814
E70506-P22814
Checkpoint Therapeutics (NASDAQ:CKPT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Checkpoint Therapeutics (NASDAQ:CKPT)
Historical Stock Chart
From Sep 2023 to Sep 2024